Venture Planning Group Market Research Reports
Sort By
| Title | Published | Price | Buy Now |
|---|---|---|---|
| 2020 Home/Self-Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood-- Sales Forecasts, Technology Trends, Competitive Strategies
By Venture Planning Group
This new 175-page report from VPGMarketResearch provides an analysis of the major home/self-testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth... |
Mar 2020 | $ 1450 | |
| 2020 Farfetch Performance, Capabilities, Goals and Strategies
By Venture Planning Group
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to ... |
Mar 2020 | $ 950 | |
| 2020 Visteon Performance, Capabilities, Goals and Strategies
By Venture Planning Group
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to ... |
Mar 2020 | $ 950 | |
| 2020 Veoneer Performance, Capabilities, Goals and Strategies
By Venture Planning Group
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to ... |
Mar 2020 | $ 950 | |
| 2020 Gentherm Performance, Capabilities, Goals and Strategies
By Venture Planning Group
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to ... |
Mar 2020 | $ 950 | |
| 2020 Aptiv Performance, Capabilities, Goals and Strategies
By Venture Planning Group
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to ... |
Mar 2020 | $ 950 | |
| 2020 Allison Transmission Performance, Capabilities, Goals and Strategies
By Venture Planning Group
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to ... |
Mar 2020 | $ 950 | |
| 2020 Capri Holdings Performance, Capabilities, Goals and Strategies
By Venture Planning Group
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to ... |
Mar 2020 | $ 950 | |
| 2020 Fibronectin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Warfarin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Rivaroxaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Fluindione Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Edoxaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Dabigatran Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Betrixaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Argatroban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Apixaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Ceruloplasmin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Transferrin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Myoglobin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Lactic Acid Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Cholinesterase Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Calcitonin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 | |
| 2020 Beta-Hydroxybutyrate Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Beta-Hydroxybutyrate testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. ... |
Mar 2020 | $ 1450 | |
| 2020 Apolipoprotein-B Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
By Venture Planning Group
This new report from VPGMarketResearch provides analysis of Apolipoprotein B testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Mar 2020 | $ 1450 |